Industries > Pharma > Plasma Fractionation Market Report 2021-2031

Back to Pharma Reports

Plasma Fractionation Market Report 2021-2031

Forecasts by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Haematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios

PAGES: 255

PRODUCT CODE: PHA0944

SUBMARKET: Next Generation Technologies

DOWNLOAD FREE SAMPLE

SKU: PHA0944 Categories: Next Generation Technologies, Pharma Tag: PHA0944

Plasma Fractionation Market-our new study reveals current trends, technological advancements, and predicted revenues

Where the Plasma Fractionation market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 250+ page report provides 150+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Plasma Fractionation market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

– In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors

– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players

– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.

Report Scope

Global Plasma Fractionation market 2021-2031 is segmented on the basis of Product and Geography.

• Revenue and growth forecasts from 2021 to 2031 for the Global Plasma Fractionation Market by Product:

–Albumin

– Immunoglobulins

– Coagulation factor VIII

–Coagulation factor IX

• Revenue and growth forecasts from 2021 to 2031 for the Global Plasma Fractionation Market by Region:

– North America: US, Canada

– Europe: Germany, UK, Italy, France, Spain, Rest of Europe

– Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific

– Latin America: Brazil, Mexico, and Rest of Latin America

– Middle East & Africa: GCC, South Africa, Rest of MEA

• Our study discusses the selected leading companies that are the major players in the Plasma Fractionation industry:

– BAXTER INTERNATIONAL INC.

–BIO PRODUCTS LABORATORY

– BIOTEST AG

– CSL LTD.

–GRIFOLS SA

– KEDRION S.P.A. (KEDRION BIOPHARMA INC.)

– LFB S. A

– OCTAPHARMA AG

– .SANQUIN BLOOD SUPPLY FOUNDATION

– TAKEDA PHARMACEUTICAL COMPANY LIMITED

How the Plasma Fractionation Market report helps you

In summary, our 190+ page report provides you with the following knowledge:
– Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.

– Revenue forecasts to 2031 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.

– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Plasma Fractionation market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

COVID 19 Impact & Recovery Analysis on the Market

Currently, COVID-19 (Coronavirus) is prevalent across the globe. Many companies are underway to discover a vaccine, or therapeutics which can prevent or cure the COVID-19 virus. According to the World Health Organization, as of 13th September 2020, there were over 28,637,952 confirmed cases of COVID-19, with more than 917,417 deaths, globally.

The COVID-19 disease is continuously disrupting the growth of various markets. However, the immediate effect of the pandemic is different. Some industries will register a drop in demand, various other markets will remain unchanged and display a promising growth opportunities. The healthcare centers, such as hospitals and diagnostic labs, have been investing heavily in maintaining the supply of essential equipment and drugs. Due to lockdown across the globe, people were unable to reach healthcare facilities and non-urgent procedures were advised to put hold which impacted the healthcare industry a lot.

Due to COVID 19 pandemic patients were reluctant in visiting hospitals or clinics for their treatments and preferred virtual doctor visits. Lockdown across the globe due to the pandemic led to the delay of procedures which were not urgent. These factors negatively impacted the plasma fractionation market for limited period of time. However, slowly the situation is getting back to normal everywhere and the market discussed is expected to increase in future.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Plasma Fractionation market and leading companies. You will find data, trends and predictions.

The Plasma Fractionation Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Plasma Fractionation industry.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Plasma Fractionation Market Report 2021-2031: Forecasts by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Haematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1. Introduction

1.2. Why You Should Read This Report

1.3. Key Questions Answered by This Analytical Report

1.4. Who is This Report For?

1.5. Methodology

1.6. Frequently Asked Questions (FAQ)

1.7. Associated VISIONGAIN Reports

1.8. About VISIONGAIN

2. Introduction to the Plasma Fractionation Market

2.1. Plasma Fractionation Market Definition

2.2. Product Submarkets Definitions

2.3. Application Submarkets Definitions

2.4. End User Submarkets Definitions

3. Plasma Fractionation Market Overview

3.1. Global Plasma Fractionation Market Size and Forecast by Region

3.2. Global Plasma Fractionation Market Share by Region

3.3. Market Dynamics

3.3.1. Market Drivers

3.3.1.1. Increasing use of immunoglobulins in various therapeutic areas

3.3.1.2. Escalating aged population

3.3.2. Market Restraints/Challenges

3.3.2.1. High price and limited compensation

3.3.2.2. Occurrence of recombinant alternatives

3.3.3. Opportunities

3.3.3.1. Increased risk of pandemics and communicable diseases

3.3.4. Global Plasma Fractionation Market: Trends

3.3.4.1. Trend 1

3.3.5. SWOT Analysis

3.3.5.1. Strengths

3.3.5.1.1. Strength 1

3.3.5.2. Weaknesses

3.3.5.2.1. Weakness 1

3.3.5.3. Opportunities

3.3.5.3.1. Opportunity 1

3.3.5.4. Threats

3.3.5.4.1. Threat 1

3.3.6. Porter’s Five Forces Analysis

3.3.6.1. Competitive Rivalry

3.3.6.2. Supplier Power

3.3.6.3. Buyer Power

3.3.6.4. Threat of Substitution

3.3.6.5. Threat of New Entry

4. Global Plasma Fractionation Market Analysis and Forecast 2020-2030, by Product (Pre COVID and V, U, W and L COVID Recovery Scenarios)

4.1. Market Overview

4.1.1. Immunoglobulins

4.1.2. Coagulation Factor Concentrates

4.1.3. Albumins

4.1.4. Protease Inhibitors

4.1.5. Other Products

5. Global Plasma Fractionation Market Analysis and Forecast, 2020-2030 by Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)

5.1. Market Overview

5.1.1. Neurology

5.1.2. Immunology

5.1.3. Hematology

5.1.4. Critical Care

5.1.5. Pulmonology

5.1.6. Hemato-Oncology

5.1.7. Rheumatology

5.1.8. Other Applications

6. Global Plasma Fractionation Market Analysis and Forecast, 2020-2030 byEnd User (Pre COVID and V, U, W and L COVID Recovery Scenarios)

6.1. Market Overview

6.1.1. Hospitals & Clinics

6.1.2. Clinical Research Laboratories

6.1.3. Academic Institutes

7. North America Plasma Fractionation Market Analysis and Forecast, 2020-2030 Pre COVID and V, U, W and L COVID Recovery Scenarios)

7.1. Market Overview

7.2. North America Plasma Fractionation Market Size and Forecast byProduct

7.3. North America Plasma Fractionation Market Size and Forecast byApplication

7.4. North America Plasma Fractionation Market Size and Forecast byEnd User

7.5. U.S. Plasma Fractionation Market

7.6. Canada Plasma Fractionation Market

8. Europe Plasma Fractionation Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

8.1. Market Overview

8.2. Europe Plasma Fractionation Market Size and Forecast by Product

8.3. Europe Plasma Fractionation Market Size and Forecast by Application

8.4. Europe Plasma Fractionation Market Size and Forecast by End User

8.5. UK Plasma Fractionation Market

8.6. Germany Plasma Fractionation Market

8.7. France Plasma Fractionation Market

8.8. Rest of Europe Plasma Fractionation Market

9. Asia Pacific Plasma Fractionation Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

9.1. Market Overview

9.2. Asia Pacific Plasma Fractionation Market Size and Forecast by Product

9.3. Asia Pacific Plasma Fractionation Market Size and Forecast by Application

9.4. Asia Pacific Plasma Fractionation Market Size and Forecast by End User

9.5. China Plasma Fractionation Market

9.6. India Plasma Fractionation Market

9.7. Japan Plasma Fractionation Market

9.8. Rest of Asia Pacific Plasma Fractionation Market

10. Latin America Plasma Fractionation Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

10.1. Market Overview

10.2. Latin America Plasma Fractionation Market Size and Forecast by Product

10.3. Latin America Plasma Fractionation Market Size and Forecast by Application

10.4. Latin America Plasma FractionationMarket Size and Forecast by End User

10.5. Brazil Plasma Fractionation Market

10.6. Mexico Plasma Fractionation Market

10.7. Rest of Latin America Plasma Fractionation Market

11. MEA Plasma Fractionation Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

11.1. Market Overview

11.2. MEA Plasma Fractionation Market Size and Forecast by Product

11.3. MEA Plasma Fractionation Market Size and Forecast by Application

11.4. MEA Plasma FractionationMarket Size and Forecast by End User

11.5. GCC Plasma Fractionation Market

11.6. South Africa Plasma Fractionation Market

11.7. Rest of MEA Plasma Fractionation Market

12. Companies in the Plasma Fractionation Market

12.1. CSL

12.1.1. Company Snapshot

12.1.2. Company Overview

12.1.3. Financial Performance (2015-2019)

12.1.3.1. Net Revenue

12.1.3.2. Gross Profit

12.1.3.3. Geographical Revenue, 2019

12.1.4. Product Offerings

12.1.5. Recent Initiatives (2017-2019)

12.2. Grifols

12.2.1. Company Snapshot

12.2.2. Company Overview

12.2.3. Financial Performance (2015-2019)

12.2.3.1. Net Revenue

12.2.3.2. Gross Profit

12.2.3.3. Geographical Revenue, 2019

12.2.4. Product Offerings

12.2.5. Recent Initiatives (2017-2019)

12.3. Octapharma

12.3.1. Company Snapshot

12.3.2. Company Overview

12.3.3. Financial Performance (2015-2019)

12.3.3.1. Net Revenue

12.3.3.2. Gross Profit

12.3.3.3. Geographical Revenue, 2019

12.3.4. Product Offerings

12.3.5. Recent Initiatives (2017-2019)

12.4. Kedrion

12.4.1. Company Snapshot

12.4.2. Company Overview

12.4.3. Financial Performance (2015-2019)

12.4.3.1. Net Revenue

12.4.3.2. Gross Profit

12.4.3.3. Geographical Revenue, 2019

12.4.4. Product Offerings

12.4.5. Recent Initiatives (2017-2019)

12.5. LFB

12.5.1. Company Snapshot

12.5.2. Company Overview

12.5.3. Financial Performance (2015-2019)

12.5.3.1. Net Revenue

12.5.3.2. Gross Profit

12.5.3.3. Geographical Revenue, 2019

12.5.4. Product Offerings

12.5.5. Recent Initiatives (2017-2019)

12.6. Sanquin

12.6.1. Company Snapshot

12.6.2. Company Overview

12.6.3. Financial Performance (2015-2019)

12.6.3.1. Net Revenue

12.6.3.2. Gross Profit

12.6.3.3. Geographical Revenue, 2019

12.6.4. Product Offerings

12.6.5. Recent Initiatives (2017-2019)

12.7. China Biologic Products

12.7.1. Company Snapshot

12.7.2. Company Overview

12.7.3. Financial Performance (2015-2019)

12.7.3.1. Net Revenue

12.7.3.2. Gross Profit

12.7.3.3. Geographical Revenue, 2019

12.7.4. Product Offerings

12.7.5. Recent Initiatives (2017-2019)

12.8. Bio Products Laboratory

12.8.1. Company Snapshot

12.8.2. Company Overview

12.8.3. Financial Performance (2015-2019)

12.8.3.1. Net Revenue

12.8.3.2. Gross Profit

12.8.3.3. Geographical Revenue, 2019

12.8.4. Product Offerings

12.8.5. Recent Initiatives (2017-2019)

12.9. Japan Blood Products Organization

12.9.1. Company Snapshot

12.9.2. Company Overview

12.9.3. Financial Performance (2015-2019)

12.9.3.1. Net Revenue

12.9.3.2. Gross Profit

12.9.3.3. Geographical Revenue, 2019

12.9.4. Product Offerings

12.9.5. Recent Initiatives (2017-2019)

12.10. GC Pharma

12.10.1. Company Snapshot

12.10.2. Company Overview

12.10.3. Financial Performance (2015-2019)

12.10.3.1. Net Revenue

12.10.3.2. Gross Profit

12.10.3.3. Geographical Revenue, 2019

12.10.4. Product Offerings

12.10.5. Recent Initiatives (2017-2019)

12.11. Other Notable Players

13. Conclusion

14. Glossary

Associated VISIONGAIN Reports

VISIONGAIN Report Sales Order Form

Appendix A

About VISIONGAIN

Appendix B

VISIONGAIN report evaluation form

List of Tables

Table No 1: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 2: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 3: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 4: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 5: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 6: Plasma Fractionation Market Drivers & Restraints 2020

Table No 7: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 8: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 9: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 10: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 11: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 12: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 13: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 14: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 15: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 16: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 17: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 18: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 19: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 20: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 21: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 22: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 23: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 24: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 25: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 26: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 27: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 28: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 29: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 30: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 31: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 32: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 33: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 34: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 35: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 36: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 37: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 38: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 39: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 40: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 41: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 42: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 43: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 44: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 45: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 46: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 47: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 48: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 49: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 50: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 51: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 52: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 53: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 54: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 55: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 56: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 57: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 58: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 59: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 60: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 61: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 62: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 63: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 64: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 65: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 66: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 67: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 68: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 69: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 70: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 71: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 72: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 73: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 74: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 75: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 76: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 77: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 78: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 79: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 80: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 81: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 82: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 83: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 84: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 85: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 86: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 87: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 88: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 89: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 90: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 91: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 92: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 93: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 94: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 95: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 96: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 97: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Table No 98: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Table No 99: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Table No 100: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Table No 101: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Table No 102: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 103: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 104: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 105: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 106: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 107: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 108: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 109: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 110: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 111: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 112: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 113: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 114: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 115: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 116: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 117: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 118: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 119: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 120: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 121: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 122: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 123: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 124: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 125: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 126: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 127: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 128: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 129: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 130: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 131: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 132: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 133: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 134: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 135: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 136: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 137: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 138: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 139: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 140: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 141: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 142: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 143: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 144: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 145: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 146: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 147: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 148: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 149: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 150: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 151: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 152: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 153: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 154: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 155: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 156: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 157: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 158: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 159: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 160: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 161: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 162: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 163: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 164: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 165: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 166: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 167: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 168: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 169: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 170: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 171: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 172: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 173: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 174: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 175: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 176: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 177: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 178: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 179: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 180: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 181: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 182: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 183: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 184: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 185: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 186: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 187: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 188: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 189: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 190: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 191: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 192: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 193: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 194: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 195: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 196: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 197: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 198: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 199: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 200: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 201: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 202: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 203: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 204: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 205: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 206: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 207: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 208: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 209: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 210: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 211: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 212: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 213: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 214: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 215: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 216: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 217: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 218: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 219: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 220: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 221: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 222: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 223: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 224: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 225: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 226: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 227: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 228: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 229: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 230: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 231: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 232: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 233: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 234: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 235: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 236: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 237: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 238: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 239: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 240: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 241: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 242: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 243: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 244: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 245: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 246: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 247: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 248: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 249: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 250: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 251: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 252: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 253: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 254: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 255: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 256: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 257: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Table No 258: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Table No 259: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Table No 260: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Table No 261: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Table No 262: Leading 10 Plasma Fractionation Market Companies (Ranking, Company, Latest Total Company Sales US $MN*, HQ)

Table No 263: CSL Profile (CEO, HQ, Founded, Website)

Table No 264: CSL (Total Company Sales 2016-2019 (US $Mn, AGR %)

Table No 265: CSL (Net Income 2016-2019 (US $Mn, AGR %)

Table No 266: Grifols Profile (CEO, HQ, Founded, Website)

Table No 267: Grifols (Total Company Sales 2016-2019 (US $Mn, AGR %)

Table No 268: Grifols (Net Income 2016-2019 (US $Mn, AGR %)

Table No 269: Octapharma Profile (CEO, HQ, Founded, Website)

Table No 270: Octapharma (Total Company Sales 2016-2019 (US $Mn, AGR %)

Table No 271: Octapharma (Net Income 2016-2019 (US $Mn, AGR %)

Table No 272: Kedrion Profile (CEO, HQ, Founded, Website)

Table No 273: Kedrion (Total Company Sales 2016-2019 (US $Mn, AGR %)

Table No 274: Kedrion (Net Income 2016-2019 (US $Mn, AGR %))

Table No 275: LFB Profile (CEO, HQ, Founded, Website)

Table No 276: LFB (Total Company Sales 2016-2019 (US $Mn, AGR %)

Table No 277: LFB (Net Income 2016-2019 (US $Mn, AGR %))

Table No 278: Sanquin Profile (CEO, HQ, Founded, Website)

Table No 279: Sanquin (Total Company Sales 2016-2019 (US $Mn, AGR %))

Table No 280: Sanquin (Net Income 2016-2019 (US $Mn, AGR %))

Table No 281: China Biologic Products Profile (CEO, HQ, Founded, Website)

Table No 282: China Biologic Products (Total Company Sales 2016-2019 (US $Mn, AGR %))

Table No 283: China Biologic Products (Net Income 2016-2019 (US $Mn, AGR %))

Table No 284: Bio Products Laboratory Profile (CEO, HQ, Founded, Website)

Table No 285: Bio Products Laboratory (Total Company Sales 2016-2019 (US $Mn, AGR %))

Table No 286: Bio Products Laboratory (Net Income 2016-2019 (US $Mn, AGR %))

Table No 287: Japan Blood Products Organization Profile (CEO, HQ, Founded, Website)

List of Figures

Figure No 1: Plasma Fractionation Market Product Overview

Figure No 2: Plasma Fractionation Market Application Overview

Figure No 3: Plasma Fractionation Market End User Overview

Figure No 4: Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %) (Before COVID)

Figure No 5: Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %) (COVID - Scenario V)

Figure No 6: Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %) (COVID - Scenario U)

Figure No 7: Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %) (COVID - Scenario W)

Figure No 8: Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %) (COVID - Scenario L)

Figure No 9: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 10: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 11: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 12: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 13: Plasma Fractionation Market Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 14: Plasma Fractionation Market Drivers & Restraints 2020

Figure No 15: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 16: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 17: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 18: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 19: Plasma Fractionation Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 20: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 21: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 22: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 23: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 24: Immunoglobulins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 25: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 26: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 27: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 28: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 29: Coagulation Factor Concentrates Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 30: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 31: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 32: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 33: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 34: Albumins Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 35: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 36: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 37: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 38: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 39: Protease Inhibitors Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 40: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 41: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 42: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 43: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 44: Other Products Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 45: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 46: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 47: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 48: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 49: Plasma Fractionation Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 50: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 51: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 52: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 53: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 54: Neurology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 55: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 56: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 57: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 58: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 59: Immunology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 60: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 61: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 62: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 63: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 64: Hematology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 65: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 66: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 67: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 68: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 69: Critical Care Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 70: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 71: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 72: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 73: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 74: Pulmonology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 75: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 76: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 77: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 78: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 79: Hemato-Oncology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 80: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 81: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 82: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 83: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 84: Rheumatology Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 85: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 86: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 87: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 88: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 89: Other Applications Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 90: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 91: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 92: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 93: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 94: Plasma Fractionation Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 95: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 96: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 97: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 98: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 99: Hospitals & Clinics Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 100: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 101: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 102: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 103: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 104: Clinical Research Laboratories Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 105: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (Before COVID)

Figure No 106: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario V)

Figure No 107: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario U)

Figure No 108: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario W)

Figure No 109: Research Institutes Submarket Forecast 2021-2031 (US $Mn, AGR %, CAGR %) (COVID - Scenario L)

Figure No 110: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 111: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 112: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 113: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 114: Regional Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 115: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 116: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 117: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 118: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 119: North America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 120: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 121: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 122: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 123: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 124: North America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 125: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 126: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 127: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 128: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 129: North America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 130: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 131: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 132: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 133: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 134: US Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 135: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 136: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 137: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 138: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 139: Canada Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 140: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 141: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 142: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 143: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 144: Europe Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 145: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 146: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 147: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 148: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 149: Europe Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 150: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 151: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 152: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 153: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 154: Europe Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 155: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 156: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 157: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 158: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 159: UK Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 160: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 161: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 162: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 163: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 164: Germany Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 165: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 166: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 167: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 168: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 169: France Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 170: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 171: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 172: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 173: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 174: Rest of Europe Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 175: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 176: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 177: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 178: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 179: Asia Pacific Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 180: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 181: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 182: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 183: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 184: Asia Pacific Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 185: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 186: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 187: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 188: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 189: Asia Pacific Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 190: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 191: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 192: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 193: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 194: China Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 195: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 196: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 197: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 198: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 199: India Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 200: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 201: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 202: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 203: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 204: Japan Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 205: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 206: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 207: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 208: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 209: RoAPAC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 210: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 211: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 212: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 213: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 214: Latin America Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 215: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 216: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 217: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 218: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 219: Latin America Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 220: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 221: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 222: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 223: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 224: Latin America Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 225: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 226: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 227: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 228: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 229: Brazil Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 230: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 231: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 232: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 233: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 234: Mexico Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 235: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 236: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 237: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 238: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 239: Rest of Latin America Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 240: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 241: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 242: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 243: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 244: Middle East and Africa Plasma Fractionation Market Forecast by Product 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 245: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 246: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 247: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 248: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 249: Middle East and Africa Plasma Fractionation Market Forecast by Application 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 250: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 251: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 252: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 253: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 254: Middle East and Africa Plasma Fractionation Market Forecast by End User 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 255: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 256: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 257: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 258: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 259: GCC Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 260: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 261: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 262: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 263: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 264: South Africa Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 265: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (Before COVID)

Figure No 266: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario V)

Figure No 267: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario U)

Figure No 268: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario W)

Figure No 269: Rest of MEA Plasma Fractionation Market Forecast 2021-2031 (US $MN, AGR %, CAGR %) (COVID - Scenario L)

Figure No 270: CSL (Total Company Sales 2016-2019 (US $Mn, AGR %)

Figure No 271: CSL (Net Income 2016-2019 (US $Mn, AGR %)

Figure No 272: Grifols (Total Company Sales 2016-2019 (US $Mn, AGR %)

Figure No 273: Grifols (Net Income 2016-2019 (US $Mn, AGR %)

Figure No 274: Abbott (Total Company Sales 2016-2019 (US $Mn, AGR %)

Figure No 275: Abbott (Net Income 2016-2019 (US $Mn, AGR %)

Figure No 276: Kedrion (Total Company Sales 2016-2019 (US $Mn, AGR %)

Figure No 277: Kedrion (Net Income 2016-2019 (US $Mn, AGR %))

Figure No 278: LFB (Total Company Sales 2016-2019 (US $Mn, AGR %)

Figure No 279: LFB (Net Income 2016-2019 (US $Mn, AGR %))

Figure No 280: Sanquin (Total Company Sales 2016-2019 (US $Mn, AGR %))

Figure No 281: Sanquin (Net Income 2016-2019 (US $Mn, AGR %))

Figure No 282: China Biologic Products (Total Company Sales 2016-2019 (US $Mn, AGR %))

Figure No 283: China Biologic Products (Net Income 2016-2019 (US $Mn, AGR %))

Figure No 284: Bio Products Laboratory (Total Company Sales 2016-2019 (US $Mn, AGR %))

Figure No 285: Bio Products Laboratory (Net Income 2016-2019 (US $Mn, AGR %))

Figure No 286: Japan Blood Products Organization (Total Company Sales 2016-2019 (US $Mn, AGR %))

Figure No 287: Japan Blood Products Organization (Net Income 2016-2019 (US $Mn, AGR %))

Figure No 288: GC Pharma (Total Company Sales 2016-2019 (US $Mn, AGR %))

Figure No 289: GC Pharma (Net Income 2016-2019 (US $Mn, AGR %))

Companies Profiled in the Report

1. Baxter International Inc.

2. Bio Products Laboratory

3. Biotest Ag

4. CSL Ltd.

5. Grifols Sa

6. Kedrion S.P.A. (Kedrion Biopharma Inc.)

7. Lfb S. A

8. Octapharma Ag

9. Sanquin Blood Supply Foundation

10. Takeda Pharmaceutical Company Limited

List of Companies Mentioned in the Report:

1. Shire

2. Sanquin

3. China Biologic Products Holdings, Inc.

4. Green Cross Corporation

5. Japan Blood Products

6. China Biologic Products

7. Shanghai RAAS Blood Products

8. Baxter International Inc.

9. Bio Products Laboratory

10. Biotest Ag

11. CSL Ltd.

12. Grifols Sa

13. Kedrion S.P.A. (Kedrion Biopharma Inc.)

14. Lfb S. A

15. Octapharma Ag

16. Sanquin Blood Supply Foundation

17. Takeda Pharmaceutical Company Limited

List of Organizations Mentioned in the Report:

• Food and Drugs Administration

• American Cancer Society

• World Health Organization

• American Hospital Association (AHA)

• National Cancer Institute

• NIH

• CDC

• Mayo Clinic

Download sample pages

Complete the form below to download your free sample pages for Plasma Fractionation Market Report 2021-2031

Download sample pages

Complete the form below to download your free sample pages for Plasma Fractionation Market Report 2021-2031

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033

The global Deep Frozen Packaging Logistics market was valued at US$21,088.3 million in 2022 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.

29 March 2023

READ

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.

20 March 2023

READ

Visiongain Publishes eClinical Solutions Market Report 2023-2033

The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.

17 March 2023

READ

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.

15 March 2023

READ

Industries > Pharma > Plasma Fractionation Market Report 2021-2031

Back to Pharma Reports

Plasma Fractionation Market Report 2021-2031

Download sample pages

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033

Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033

Visiongain Publishes eClinical Solutions Market Report 2023-2033

Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033

Our Clients